Donald Ortiz, MD
Family Medicine · Albuquerque, NMNPI 1841309176
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 402 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,677 and has fallen 82.4% since, to $296 in 2025. Among family medicine clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 402 payments — averaging $16.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Lilly USA, LLC$578
- AbbVie$460
- Boehringer Ingelheim$452
- Pfizer$450
- Novo Nordisk$430
- plus $3K from 35 others
What the payments were for
- Food & beverage$6,532100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 43 | $1,267 |
| Lilly USA, LLC | 52 | $578 |
| AbbVie(2 entities) | 36 | $460 |
| Boehringer Ingelheim | 26 | $452 |
| Pfizer | 40 | $450 |
| Novo Nordisk | 34 | $430 |
| Merck | 29 | $362 |
| Sanofi-aventis U.S. LLC | 17 | $281 |
| Johnson & Johnson | 20 | $264 |
| Amgen | 11 | $208 |
| Biohaven Pharmaceuticals, Inc. | 4 | $199 |
| Exact Sciences | 9 | $197 |
| Nestle Healthcare Nutrition Inc. | 10 | $170 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $145 |
| Teva Pharmaceuticals USA, Inc. | 8 | $143 |
| Novartis | 8 | $136 |
| Amarin Pharma, Inc. | 8 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Dexcom, Inc. | 3 | $66 |
| Abbott | 2 | $55 |
| Bayer | 3 | $49 |
| Upsher-smith Laboratories LLC | 2 | $37 |
| Organon | 2 | $35 |
| Eisai Inc. | 2 | $33 |
| GRT US Holding, Inc. | 2 | $32 |
| GSK | 1 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Nevro Corp. | 1 | $22 |
| Nabriva Therapeutics, PLC | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| MDD US Operations, LLC | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| BD | 1 | $17 |
| Axonics, Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Boston Scientific | 1 | $14 |
| Metacel Pharmaceuticals LLC | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMBICORT$227
- FARXIGA$227
- NURTEC ODT$124
- BREZTRI$123
How this compares
$6,545 in reported general payments places this provider in the 95th percentile of 717 family medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 43 | $53,163 |
| TrulicityDulaglutide | 16 | $16,999 |
| EliquisApixaban | 26 | $15,844 |
| XareltoRivaroxaban | 17 | $15,382 |
| SymbicortBudesonide/Formoterol Fumarate | 32 | $9,004 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 233 | $7,304 |
| Oxycodone Hcl | 239 | $5,451 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 138 | $4,960 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $4,428 |
| Gabapentin | 153 | $3,488 |
| Atorvastatin Calcium | 190 | $2,983 |
| PremproEstrogen,con/M-Progest Acet | 11 | $2,673 |
| Ventolin HfaAlbuterol Sulfate | 39 | $2,606 |
| Amlodipine Besylate | 204 | $2,330 |
| Levothyroxine Sodium | 141 | $2,251 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $430 | $53,16343 claims |
| PfizerEliquis, Prempro, Paxlovid | $450 | $19,94748 claims |
| Lilly USA, LLCTrulicity | $578 | $16,99916 claims |
| Johnson & JohnsonXarelto | $264 | $15,38217 claims |
| AstraZenecaSymbicort | $1,267 | $9,00432 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 717 family medicine providers in New Mexico.
Other family medicine in Albuquerque
- Carletta BullockAlbuquerque$60K
- Robert BairAlbuquerque$44K
- Timothy GrenemyerAlbuquerque$10K
- Cheri BlackstenAlbuquerque$9K
- Michael MontoyaAlbuquerque$7K
- Yvonne Vanarsdale-ImaniAlbuquerque$7K
- Satkirin KhalsaAlbuquerque$6K
- Angela RomeroAlbuquerque$5K
- H Preston MatthewsAlbuquerque$5K
- John StuartAlbuquerque$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.